Clinical Trial Update: Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS) [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study evaluating inhaled carbon monoxide for Acute Respiratory Distress Syndrome is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Inhaled carbon monoxide (carbon monoxide inhalation)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Acute Respiratory Distress Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING